HEC116094 Shows Potent Activity as PB2 Inhibitor Against Influenza A Virus
HEC116094 demonstrates potent in vitro and in vivo activity against influenza A virus, outperforming existing therapies.
Asset / Drug
Drug and asset intelligence for HEC116094 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.